c-clav suspension suspension and effervescent granules for oral
oriana limited p.o box 19528-00202, nairobi - cefixime trihydrate usp equiv. to cefixime and - suspension and effervescent granules for oral - cefixime trihydrate usp equiv. to cefixime 50.00 - cefixime
suprax cefixime tablet
lupin limited - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg
suprax- cefixime powder, for suspension
lupin pharmaceuticals, inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 100 mg in 5 ml - suprax is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of escherichia coli and proteus mirabilis . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of haemophilus influenzae , moraxella catarrhalis , and streptococcus pyogenes. (efficacy for streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) note: for patients with otitis media caused by streptococcus pneumoniae , overall response was approximately 10% lower for cefixime than for the comparator [see clinical studies (14)] . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused by susceptible isolates of streptococcus pyogenes. (note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes infections.
suprax- cefixime capsule
pd-rx pharmaceuticals, inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg - suprax is indicated in the treatment of adults and pediatric patients six months of age or older with uncomplicated urinary tract infections caused by susceptible isolates of escherichia coli and proteus mirabilis . suprax is indicated in the treatment of adults and pediatric patients six months of age or older with otitis media caused by susceptible isolates of haemophilus influenzae , moraxella catarrhalis , and streptococcus pyogenes. (efficacy for streptococcus pyogenes in this organ system was studied in fewer than 10 infections.) note: for patients with otitis media caused by streptococcus pneumoniae , overall response was approximately 10% lower for cefixime than for the comparator [see clinical studies ( 14)]. suprax is indicated in the treatment of adults and pediatric patients six months of age or older with pharyngitis and tonsillitis caused by susceptible isol
cefexol ds suspension powder for oral suspension
nabiqasim industries (pvt.) ltd. 17/24, korangi industrial area, karachi - cefixime (as trihydrate) - powder for oral suspension - each 5ml contains: cefixime(as trihydrate)……200mg - cefixime
cefexol suspension powder for oral suspension
nabiqasim industries (pvt.) ltd. 17/24, korangi industrial area, karachi - cefixime (as trihydrate) - powder for oral suspension - each 5ml contains: cefixime(as trihydrate)……100mg - cefixime
cefixime 400mg tablets
rivopharm (uk) ltd - cefixime - oral tablet - 400mg
cefixime nectar lifesciences 100 mg/5 ml powder for oral suspension
nectar lifesciences uk limited - cefixime - powder for oral suspension - 100/5 milligram(s)/millilitre - cefaclor
cefixime nectar lifesciences 100 mg/5 ml powder for oral suspension
neclife pt unipessoal lda - cefixime - powder for oral suspension - 100/5 milligram(s)/millilitre - cefaclor
auro-cefixime powder for suspension
auro pharma inc - cefixime - powder for suspension - 100mg - cefixime 100mg - third generation cephalosporins